Conventional androgen deprivation therapy is associated with an increased risk of cardiovascular disease in advanced prostate cancer, a nationwide population-based study.

<h4>Purpose</h4>Androgen Deprivation Therapy (ADT) is the mainstay treatment in advanced prostate cancer. We conducted a nationwide population-based study to evaluate the association of ADT and cardiovascular diseases.<h4>Methods</h4>Between 2005 and 2009, patient data from t...

Full description

Bibliographic Details
Main Authors: Jian-Ri Li, Shian-Shiang Wang, Chuan-Shu Chen, Chen-Li Cheng, Sheng-Chun Hung, Ching-Heng Lin, Kun-Yuan Chiu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0270292
_version_ 1811294899217104896
author Jian-Ri Li
Shian-Shiang Wang
Chuan-Shu Chen
Chen-Li Cheng
Sheng-Chun Hung
Ching-Heng Lin
Kun-Yuan Chiu
author_facet Jian-Ri Li
Shian-Shiang Wang
Chuan-Shu Chen
Chen-Li Cheng
Sheng-Chun Hung
Ching-Heng Lin
Kun-Yuan Chiu
author_sort Jian-Ri Li
collection DOAJ
description <h4>Purpose</h4>Androgen Deprivation Therapy (ADT) is the mainstay treatment in advanced prostate cancer. We conducted a nationwide population-based study to evaluate the association of ADT and cardiovascular diseases.<h4>Methods</h4>Between 2005 and 2009, patient data from the National Health Insurance database were obtained. We divided newly diagnosed prostate cancer patients into four groups, injection of gonadotropin-releasing hormone agonists and antagonists, oral antiandrogens, orchiectomy and radical prostatectomy only. Another matched non-cancerous control group was also assigned for comparison purposes. Study outcomes were newly onset Cardiovascular Diseases (CVD) and hospital admissions. Multi-variant Cox proportional regression analysis and the Kaplan-Meier method for cumulative incidence were performed.<h4>Results</h4>A total of 17,147 newly diagnosed prostate cancer patients were found. After exclusion criteria was considered, the 2,565 remaining patients were then divided into 1,088 subjects in the injection group, 286 in the orchiectomy group, 812 in the oral group and 379 in the radical prostatectomy only group. The mean age of all the patients was 71.2 years. Multi-variant analysis showed a significantly increased risk of CVD in the injection group, orchiectomy group, oral group and radical prostatectomy group (HR = 2.94, 95% CI 2.51 to 3.45, p<0.001, HR = 3.43, 95% CI 2.69 to 4.36, p<0.001, HR = 2.87, 95% CI 2.42 to 3.39, p<0.001, HR = 1.93, 95% CI 1.5 to 2.48, p<0.001, respectively). A time dependent increased risk of CVD was also observed amongst the study groups (p<0.001).<h4>Conclusions</h4>ADT is associated with an increased risk of CVD. For long-term prostate cancer castration therapy, doctors should be aware of this complication and arrange for proper management.
first_indexed 2024-04-13T05:24:22Z
format Article
id doaj.art-f3a4e3cd17e247e9a8ce69f56251a8f4
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T05:24:22Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-f3a4e3cd17e247e9a8ce69f56251a8f42022-12-22T03:00:39ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01176e027029210.1371/journal.pone.0270292Conventional androgen deprivation therapy is associated with an increased risk of cardiovascular disease in advanced prostate cancer, a nationwide population-based study.Jian-Ri LiShian-Shiang WangChuan-Shu ChenChen-Li ChengSheng-Chun HungChing-Heng LinKun-Yuan Chiu<h4>Purpose</h4>Androgen Deprivation Therapy (ADT) is the mainstay treatment in advanced prostate cancer. We conducted a nationwide population-based study to evaluate the association of ADT and cardiovascular diseases.<h4>Methods</h4>Between 2005 and 2009, patient data from the National Health Insurance database were obtained. We divided newly diagnosed prostate cancer patients into four groups, injection of gonadotropin-releasing hormone agonists and antagonists, oral antiandrogens, orchiectomy and radical prostatectomy only. Another matched non-cancerous control group was also assigned for comparison purposes. Study outcomes were newly onset Cardiovascular Diseases (CVD) and hospital admissions. Multi-variant Cox proportional regression analysis and the Kaplan-Meier method for cumulative incidence were performed.<h4>Results</h4>A total of 17,147 newly diagnosed prostate cancer patients were found. After exclusion criteria was considered, the 2,565 remaining patients were then divided into 1,088 subjects in the injection group, 286 in the orchiectomy group, 812 in the oral group and 379 in the radical prostatectomy only group. The mean age of all the patients was 71.2 years. Multi-variant analysis showed a significantly increased risk of CVD in the injection group, orchiectomy group, oral group and radical prostatectomy group (HR = 2.94, 95% CI 2.51 to 3.45, p<0.001, HR = 3.43, 95% CI 2.69 to 4.36, p<0.001, HR = 2.87, 95% CI 2.42 to 3.39, p<0.001, HR = 1.93, 95% CI 1.5 to 2.48, p<0.001, respectively). A time dependent increased risk of CVD was also observed amongst the study groups (p<0.001).<h4>Conclusions</h4>ADT is associated with an increased risk of CVD. For long-term prostate cancer castration therapy, doctors should be aware of this complication and arrange for proper management.https://doi.org/10.1371/journal.pone.0270292
spellingShingle Jian-Ri Li
Shian-Shiang Wang
Chuan-Shu Chen
Chen-Li Cheng
Sheng-Chun Hung
Ching-Heng Lin
Kun-Yuan Chiu
Conventional androgen deprivation therapy is associated with an increased risk of cardiovascular disease in advanced prostate cancer, a nationwide population-based study.
PLoS ONE
title Conventional androgen deprivation therapy is associated with an increased risk of cardiovascular disease in advanced prostate cancer, a nationwide population-based study.
title_full Conventional androgen deprivation therapy is associated with an increased risk of cardiovascular disease in advanced prostate cancer, a nationwide population-based study.
title_fullStr Conventional androgen deprivation therapy is associated with an increased risk of cardiovascular disease in advanced prostate cancer, a nationwide population-based study.
title_full_unstemmed Conventional androgen deprivation therapy is associated with an increased risk of cardiovascular disease in advanced prostate cancer, a nationwide population-based study.
title_short Conventional androgen deprivation therapy is associated with an increased risk of cardiovascular disease in advanced prostate cancer, a nationwide population-based study.
title_sort conventional androgen deprivation therapy is associated with an increased risk of cardiovascular disease in advanced prostate cancer a nationwide population based study
url https://doi.org/10.1371/journal.pone.0270292
work_keys_str_mv AT jianrili conventionalandrogendeprivationtherapyisassociatedwithanincreasedriskofcardiovasculardiseaseinadvancedprostatecanceranationwidepopulationbasedstudy
AT shianshiangwang conventionalandrogendeprivationtherapyisassociatedwithanincreasedriskofcardiovasculardiseaseinadvancedprostatecanceranationwidepopulationbasedstudy
AT chuanshuchen conventionalandrogendeprivationtherapyisassociatedwithanincreasedriskofcardiovasculardiseaseinadvancedprostatecanceranationwidepopulationbasedstudy
AT chenlicheng conventionalandrogendeprivationtherapyisassociatedwithanincreasedriskofcardiovasculardiseaseinadvancedprostatecanceranationwidepopulationbasedstudy
AT shengchunhung conventionalandrogendeprivationtherapyisassociatedwithanincreasedriskofcardiovasculardiseaseinadvancedprostatecanceranationwidepopulationbasedstudy
AT chinghenglin conventionalandrogendeprivationtherapyisassociatedwithanincreasedriskofcardiovasculardiseaseinadvancedprostatecanceranationwidepopulationbasedstudy
AT kunyuanchiu conventionalandrogendeprivationtherapyisassociatedwithanincreasedriskofcardiovasculardiseaseinadvancedprostatecanceranationwidepopulationbasedstudy